{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:00:09Z","timestamp":1793678409347,"version":"4.5.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijrobp.2024.06.017","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:27:34Z","timestamp":1720096054000},"page":"1307-1325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy"],"prefix":"10.1016","volume":"120","author":[{"given":"Jan","family":"Hrbacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kacperek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem M.","family":"Beenakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Denker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelf","family":"Slopsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Heufelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.06.017_bib0001","unstructured":"Particle Therapy Co-Operative Group (PTCOG). PTCOG website. Available at: https:\/\/www.ptcog.ch\/. Accessed July 23, 2024."},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0002","unstructured":"PTCOG OPTIC. First International PTCOG Ocular Proton Therapy Symposium 2022 - YouTube channel. 2022. Available at: https:\/\/www.youtube.com\/playlist?list=PLx7XfOFbYiIuq2md8L3ormJ0Z6zyuG-Rl. Accessed July 23, 2024."},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0003","unstructured":"PTCOG OPTIC. First International PTCOG Ocular Proton Therapy Symposium 2022 - website. 2022. Available at: https:\/\/indico.psi.ch\/event\/12099\/. Accessed July 23, 2024."},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0004","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0005","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2015.01.029","article-title":"Long-term results of the UCSF-LBNL randomized trial: Charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanoma","volume":"92","author":"Mishra","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0360-3016(99)00147-9","article-title":"Results of proton therapy of uveal melanomas treated in Nice","volume":"45","author":"Courdi","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0007","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/112067210901900421","article-title":"Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France","volume":"19","author":"Mosci","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0008","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.clon.2016.01.034","article-title":"Clinical outcomes of proton radiotherapy for uveal melanoma","volume":"28","author":"Verma","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000433546","article-title":"Outcomes of proton beam radiotherapy for large non-peripapillary choroidal and ciliary body melanoma at TRIUMF and the BC Cancer Agency","volume":"2","author":"Weber","year":"2015","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apradiso.2008.06.012","article-title":"Protontherapy of eye tumours in the UK: A review of treatment at Clatterbridge","volume":"67","author":"Kacperek","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0011","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00066-004-1222-5","article-title":"Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute","volume":"180","author":"H\u00f6cht","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0012","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/17469899.2015.1120671","article-title":"Proton beam radiotherapy for uveal melanoma","volume":"10","author":"Afshar","year":"2015","journal-title":"Exp Rev Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0013","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1109\/TNS.2004.829535","article-title":"A 62-MeV proton beam for the treatment of ocular melanoma at laboratori nazionali del sud-INFN","volume":"51","author":"Cirrone","year":"2004","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0014","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0360-3016(89)90099-0","article-title":"Conservative treatment of uveal melanoma: Local recurrence after proton beam therapy","volume":"17","author":"Munzenrider","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0016","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1167\/iovs.06-0659","article-title":"Proton beam irradiation of uveal melanomas: The first 30 years. The Weisenfeld Lecture","volume":"47","author":"Gragoudas","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0017","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.iio.0000195853.85581.c0","article-title":"Proton teletherapy of uveal melanoma","volume":"46","author":"Char","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0019","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay proton therapy center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ajo.2004.01.006","article-title":"Survival after proton-beam irradiation of uveal melanomas","volume":"137","author":"Kodjikian","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0021","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0360-3016(00)01430-9","article-title":"Proton radiation therapy for medium and large choroidal melanoma: Preservation of the eye and its functionality","volume":"49","author":"Fuss","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0022","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2009.12.018","article-title":"Uveal melanoma recurrence after fractionated proton beam therapy: Comparison of survival in patients treated with reirradiation or with enucleation","volume":"79","author":"Marucci","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0023","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","article-title":"Local recurrence after primary proton beam therapy in uveal melanoma: Risk factors, retreatment approaches, and outcome","volume":"160","author":"Seibel","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0024","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye retention after proton beam radiotherapy for uveal melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0025","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(89)32738-2","article-title":"The risk of enucleation after proton beam irradiation of uveal melanoma","volume":"96","author":"Egan","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0026","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-20-1247","article-title":"Tebentafusp, a TCR\/Anti-CD3 bispecific fusion protein targeting gp100, potently activated antitumor immune responses in patients with metastatic melanoma","volume":"26","author":"Middleton","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0027","doi-asserted-by":"crossref","first-page":"646","DOI":"10.6004\/jnccn.2018.0042","article-title":"New NCCN guidelines for uveal melanoma and treatment of recurrent or progressive distant metastatic melanoma","volume":"16","author":"Barker","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0028","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1055\/a-1534-0198","article-title":"Uveal melanoma \u2013 standardised procedure in diagnosis, therapy and surveillance","volume":"238","author":"Bechrakis","year":"2021","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0029","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ijrobp.2012.10.005","article-title":"Local recurrence after uveal melanoma proton beam therapy: Recurrence types and prognostic consequences","volume":"85","author":"Caujolle","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0030","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ajo.2014.07.013","article-title":"Salvage proton beam therapy in local recurrent uveal melanoma","volume":"158","author":"Riechardt","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjopt.2013.06.014","article-title":"Proton beam radiotherapy of uveal melanoma","volume":"27","author":"Damato","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0032","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/eye.2010.85","article-title":"Agreement between image grading of conventional (45\u00b0) and ultra wide-angle (200\u00b0) digital images in the macula in the Reykjavik eye study","volume":"24","author":"Csutak","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0033","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/eye.2012.267","article-title":"Pitfalls in colour photography of choroidal tumours","volume":"27","author":"Schalenbourg","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0034","first-page":"1001","article-title":"Multimodal imaging of the choroidal melanoma, with differential diagnosis, therapy (radiation planning) and follow-up","volume":"235","author":"N\u00fcrnberg","year":"2018","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00234-021-02825-5","article-title":"MR imaging characteristics of uveal melanoma with histopathological validation","volume":"64","author":"Ferreira","year":"2022","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0036","article-title":"Inter-observer variability in MR-based target volume delineation of uveal melanoma","volume":"8","author":"Jaarsma-Coes","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2022.06.021","article-title":"MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy","volume":"174","author":"Via","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0038","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1111\/aos.13413","article-title":"Fundus autofluorescence of choroidal nevi and melanoma","volume":"96","author":"Cennamo","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0039","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ICU.0000000000000560","article-title":"Small choroidal melanoma: Detection with multimodal imaging and management with plaque radiotherapy or AU-011 nanoparticle therapy","volume":"30","author":"Shields","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0040","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/eye.2017.14","article-title":"Evaluation of choroidal tumors with optical coherence tomography: Enhanced depth imaging and OCT-angiography features","volume":"31","author":"Cennamo","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0041","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/mp.16006","article-title":"Commissioning and validation of a novel commercial TPS for ocular proton therapy","volume":"50","author":"Wulff","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0042","unstructured":"Cordini D. Einf\u00fchrung eines therapieplanungssystems f\u00fcr die protonentherapie von augentumoren in die klinische routine. 2017. doi:10.17169\/REFUBIUM-4675"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0043","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2016.01.040","article-title":"Practice patterns analysis of ocular proton therapy centers: The international OPTIC survey","volume":"95","author":"Hrbacek","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0044","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4236\/ijmpcero.2018.73029","article-title":"Proton beam ocular treatment in eyes with intraocular silicone oil: Effects on physical beam parameters and clinical relevance of silicone oil in EYEPLAN dose-volume histograms","volume":"7","author":"Daftari","year":"2018","journal-title":"Int J Med Physics Clin Eng Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0045","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjophthalmol-2020-318063","article-title":"Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field)","volume":"106","author":"Oxenreiter","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0046","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/bjophthalmol-2014-305174","article-title":"Proton beam radiotherapy of diffuse iris melanoma in 54 patients","volume":"99","author":"Willerding","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0047","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.oret.2022.08.026","article-title":"Proton therapy for 166 patients with iris melanoma: Side effects and oncologic outcomes","volume":"7","author":"Gollrad","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0048","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/mp.12841","article-title":"Noninvasive eye localization in ocular proton therapy through optical eye tracking: A proof of concept","volume":"45","author":"Via","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0049","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/mp.14087","article-title":"Technical note: Benchmarking automated eye tracking and human detection for motion monitoring in ocular proton therapy","volume":"47","author":"Via","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0050","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1118\/1.4915921","article-title":"Optical eye tracking system for real-time noninvasive tumor localization in external beam radiotherapy","volume":"42","author":"Via","year":"2015","journal-title":"Med Phys"},{"issue":"13","key":"10.1016\/j.ijrobp.2024.06.017_bib0051","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac0afb","article-title":"Non-invasive recognition of eye torsion through optical imaging of the iris pattern in ocular proton therapy","volume":"66","author":"Spaccapaniccia","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0052","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1088\/0031-9155\/47\/4\/304","article-title":"Precise modelling of the eye for proton therapy of intra-ocular tumours","volume":"47","author":"Dobler","year":"2002","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0053","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1088\/0031-9155\/46\/3\/304","article-title":"Real-time dose calculation and visualization for the proton therapy of ocular tumours","volume":"46","author":"Pfeiffer","year":"2001","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0054","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1078\/0939-3889-00190","article-title":"Five years of proton therapy of eye neoplasms at the Hahn-Meitner Institute, Berlin","volume":"14","author":"Heufelder","year":"2004","journal-title":"Z Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0055","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1088\/0031-9155\/57\/24\/8325","article-title":"The influence of silicone oil used in ophthalmology on the proton therapy of uveal melanomas","volume":"57","author":"Weber","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0056","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/cancers11030377","article-title":"MRI of uveal melanoma","volume":"11","author":"Ferreira","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0057","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13244-021-01000-x","article-title":"Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part I: MR imaging with pathologic correlation and technical considerations","volume":"12","author":"Foti","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0058","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00247-011-2201-5","article-title":"Guidelines for imaging retinoblastoma: Imaging principles and MRI standardization","volume":"42","author":"de Graaf","year":"2012","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0059","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10334-016-0529-4","article-title":"Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning","volume":"29","author":"Beenakker","year":"2016","journal-title":"MAGMA"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.oret.2022.06.019","article-title":"Comparison of magnetic resonance imaging-based and conventional measurements for proton beam therapy of uveal melanoma","volume":"7","author":"Jaarsma-Coes","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0061","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2020.08.023","article-title":"Potential and pitfalls of 1.5T MRI imaging for target volume definition in ocular proton therapy","volume":"154","author":"Via","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0062","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3174\/ajnr.A3619","article-title":"Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate","volume":"35","author":"Sepahdari","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0063","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phro.2022.11.001","article-title":"Automatic three-dimensional magnetic resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma","volume":"24","author":"Klaassen","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0064","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00234-023-03166-1","article-title":"MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma","volume":"65","author":"Tang","year":"2023","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11547-016-0697-3","article-title":"Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up","volume":"122","author":"Foti","year":"2017","journal-title":"Radiol Med"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0066","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.3390\/cancers15112995","article-title":"Magnetic resonance imaging in the clinical care for uveal melanoma patients-a systematic review from an ophthalmic perspective","volume":"15","author":"Jaarsma-Coes","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ijrobp.2024.06.017_bib0067","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3872","article-title":"Multiband diffusion-weighted MRI of the eye and orbit free of geometric distortions using a RARE-EPI hybrid","volume":"31","author":"Paul","year":"2018","journal-title":"NMR Biomed"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0068","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/mrm.26534","article-title":"Magnetic resonance safety and compatibility of tantalum markers used in proton beam therapy for intraocular tumors: A 7.0 Tesla study","volume":"78","author":"Oberacker","year":"2017","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0069","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00066-006-1512-1","article-title":"Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning","volume":"182","author":"Marnitz","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mp.14665","article-title":"Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy","volume":"48","author":"Fleury","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0071","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1118\/1.595258","article-title":"Planning proton therapy of the eye","volume":"10","author":"Goitein","year":"1983","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0072","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1118\/1.3488891","article-title":"Fundus image fusion in EYEPLAN software: An evaluation of a novel technique for ocular melanoma radiation treatment planning","volume":"37","author":"Daftari","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0073","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1118\/1.2068927","article-title":"3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques","volume":"32","author":"Ik","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0074","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.oret.2022.05.006","article-title":"A comparison of treatment outcomes after standard dose (70 Gy) versus reduced dose (50 Gy) proton radiation in patients with uveal melanoma","volume":"6","author":"Lane","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21037\/cco.2016.07.06","article-title":"Proton therapy for the management of uveal melanoma and other ocular tumors","volume":"5","author":"Mishra","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0076","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/mp.15573","article-title":"Technical note: Impact of beam properties for uveal melanoma proton therapy-an in silico planning study","volume":"49","author":"Wulff","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0077","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1118\/1.2168067","article-title":"Dose distributions of a proton beam for eye tumor therapy: Hybrid pencil-beam ray-tracing calculations","volume":"33","author":"Rethfeldt","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0078","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2016.02.039","article-title":"Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique","volume":"95","author":"Hartsell","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0079","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.canrad.2022.03.003","article-title":"Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study","volume":"26","author":"Gerard","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0080","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1038\/s41598-022-08440-5","article-title":"Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline","volume":"12","author":"Regmi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0081","series-title":"Principles and Practice of Particle Therapy","first-page":"201","article-title":"Ocular malignancies","author":"Mishra","year":"2022"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0082","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ijrobp.2018.02.008","article-title":"Automated treatment planning system for uveal melanomas treated with proton therapy: A proof-of-concept analysis","volume":"101","author":"Hennings","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0083","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2016.09.019","article-title":"Temporal evolution and dose-volume histogram predictors of visual acuity after proton beam radiation therapy of uveal melanoma","volume":"97","author":"Polishchuk","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0084","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2009.07.1688","article-title":"Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years\u2019 experience","volume":"78","author":"Caujolle","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijrobp.2015.12.011","article-title":"Visual outcomes of parapapillary uveal melanomas following proton beam therapy","volume":"95","author":"Thariat","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0086","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ICO.0000000000001063","article-title":"Limbal stem cell preservation during proton beam irradiation for diffuse iris melanoma","volume":"36","author":"Singh","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0087","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000496847","article-title":"Diffuse iris melanoma: conservative treatment with proton beam therapy after limbal stem cell preservation or enucleation?","volume":"5","author":"Leblanc","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0088","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/bjophthalmol-2014-305313","article-title":"Transpalpebral proton beam radiotherapy of choroidal melanoma","volume":"99","author":"Konstantinidis","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102551","article-title":"Improved lateral penumbra for proton ocular treatments on a general-purpose spot scanning beamline","volume":"107","author":"Saini","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0090","series-title":"Ion Beam Therapy Fundamentals, Technology, Clinical Applications","first-page":"149","article-title":"Ocular proton therapy centers","author":"Kacperek","year":"2012"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0091","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1002\/mp.15024","article-title":"Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison","volume":"48","author":"Fleury","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0092","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1088\/0031-9155\/52\/13\/021","article-title":"Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy","volume":"52","author":"Newhauser","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0093","unstructured":"International Atomic Energy Agency. Absorbed dose determination in external beam radiotherapy. In Atomic Energy, Technical Reports Series No. 398. Vienna: International Atomic Energy Agency; 2000:1-229. Available at: https:\/\/www.iaea.org\/publications\/5954\/absorbed-dose-determination-in-external-beam-radiotherapy. Accessed July 23, 2024."},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0094","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1118\/1.4947547","article-title":"The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management","volume":"43","author":"Huq","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0095","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1002\/mp.13622","article-title":"AAPM task group 224: Comprehensive proton therapy machine quality assurance","volume":"46","author":"Arjomandy","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0096","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1002\/mp.14030","article-title":"Strategies for effective physics plan and chart review in radiation therapy: Report of AAPM Task Group 275","volume":"47","author":"Ford","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0097","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2021.01.030","article-title":"Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma","volume":"157","author":"van Beek","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0098","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2012.249","article-title":"Effects of radiotherapy on uveal melanomas and adjacent tissues","volume":"27","author":"Groenewald","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0099","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00417-017-3834-3","article-title":"Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy","volume":"256","author":"Mahdjoubi","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0100","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-016-3429-4","article-title":"Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma","volume":"254","author":"Seibel","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0101","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ceo.13928","article-title":"Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors","volume":"49","author":"Jabbarli","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0102","doi-asserted-by":"crossref","unstructured":"Jabbarli L, Biewald E, Guberina M, et al. Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanoma. Eur J Ophthalmol. e-pub ahead of print, May 2024. doi:10.1177\/11206721241257979","DOI":"10.1177\/11206721241257979"},{"issue":"SUPPL 5","key":"10.1016\/j.ijrobp.2024.06.017_bib0103","article-title":"Proton therapy for uveal melanoma in Adolescents\/Young adults (AYAs) and adults: A matched cohort analysis","volume":"68","author":"Pica","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0104","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00417-018-4036-3","article-title":"Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma","volume":"256","author":"Busch","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ophtha.2020.06.030","article-title":"Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanoma","volume":"128","author":"Espensen","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: A detailed analysis of tumor and dose-volume parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0107","doi-asserted-by":"crossref","first-page":"10066","DOI":"10.3390\/ijms221810066","article-title":"Vitreoretinal surgery in the prevention and treatment of toxic tumour syndrome in uveal melanoma: A systematic review","volume":"22","author":"Romano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0108","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1177\/11206721221085409","article-title":"Treatment and prophylaxis of radiation optic neuropathy: A systematic review and meta-analysis","volume":"32","author":"Yu","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0109","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1177\/11206721211067331","article-title":"OCT-angiography for the diagnosis of radiation maculopathy in patients treated with proton beam therapy: A 2-year prospective study","volume":"32","author":"Marin","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijrobp.2012.08.026","article-title":"Charged particle radiation therapy for uveal melanoma: A systematic review and meta-analysis","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0111","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0161-6420(02)01174-0","article-title":"Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy","volume":"109","author":"Char","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0112","unstructured":"National Comprehensive Cancer Network. Uveal melanoma. Version 1.2023. 2023. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uveal.pdf. Accessed May 8, 2024."},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0113","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/eye.2015.109","article-title":"Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma","volume":"29","author":"Sikuade","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127814","article-title":"Cost-effectiveness of proton beam therapy for intraocular melanoma","volume":"10","author":"Moriarty","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0115","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1088\/0031-9155\/52\/19\/016","article-title":"Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy","volume":"52","author":"Zytkovicz","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0116","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2022.12.021","article-title":"Robotic CyberKnife radiosurgery for the treatment of choroidal and ciliary body melanoma","volume":"250","author":"Liegl","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0117","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma","volume":"98","author":"Yazici","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2010.04.035","article-title":"Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"81","author":"Dunavoelgyi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.017_bib0119","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2013-304501","article-title":"Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy","volume":"98","author":"Konstantinidis","year":"2014","journal-title":"Br J Ophthalmol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162400748X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162400748X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T18:27:50Z","timestamp":1731608870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162400748X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S036030162400748X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}